Table 1

Baseline characteristics of study patients

Supplement group
(n = 106)No-supplement group
(n = 100)P value
Sex0.71
 Male60 (57)54 (54)
 Female46 (43)46 (46)
Age (years)58 ± 1057 ± 110.53
Race0.38
 Black88 (83)79 (79)
 White17 (16)17 (17)
 Other1 (1)4 (4)
BMI (kg/m2)33.7 ± 9.033.0 ± 8.80.60
Body weight (kg)99.9 ± 29.197.4 ± 25.60.73
Diabetes duration (years)12 ± 910 ± 80.12
Admission service0.02
 Medicine63 (59)75 (75)
 Surgery43 (41)25 (25)
Hospital length of stay (days)7 (4–13)6 (5–9)0.50
eGFR (mL/min/1.73 m2)80 ± 2982 ± 270.55
Serum creatinine (μmol/L [mg/dL])106 ± 35 [1.2 ± 0.4]97 ± 35 [1.1 ± 0.4]0.53
Diabetes admission therapy0.95
 Diet alone13 (12)13 (13)
 Oral agents34 (32)33 (33)
 Insulin40 (38)39 (39)
 Insulin and oral agents18 (17)14 (14)
  • Data are n (%), mean ± SD, or median (25th–75th interquartile range). eGFR, estimated glomerular filtration rate.